Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

PURPOSE Tumor host microenvironment plays an important role in tumor growth, metastasis, and response to cancer therapy. In this study, the influence of tumor host environment on tumor pathophysiology, photosensitizer distribution, and photodynamic therapy (PDT) treatment effect was examined in the metastatic at lymph node and lung (MatLyLu) rat prostate tumor. EXPERIMENTAL DESIGN MatLyLu tumors implanted in different host environment [i.e., orthotopically (in the prostate) or s.c.] were compared for difference in vessel density, average vessel size, vascular permeability, tumor vascular endothelial growth factor production, and tumor oxygenation. Uptake of photosensitizer verteporfin in tumors in both sites was determined by fluorescence microscopy. To compare tumor response to PDT, both orthotopic and s.c. MatLyLu tumors were given the same doses of verteporfin and laser light treatment, and PDT-induced tumor necrotic area was measured histologically. RESULTS Orthotopic MatLyLu tumors were found to grow faster, have higher vessel density and more permeable vasculature, have higher vascular endothelial growth factor protein levels, and have lower tumor hypoxic fraction than the s.c. tumors. Uptake of photosensitizer verteporfin in the orthotopic tumor was higher than in the s.c. tumors at 15 minutes after injection (1 mg/kg, i.v.), and became similar at 3 hours after injection. For the vascular targeting PDT treatment (0.25 mg/kg verteporfin, 50 J/cm(2) at 50 mW/cm(2), 15 minutes drug-light interval), there was no significant difference in PDT-induced tumor necrotic area between the orthotopic and s.c. tumors, with 85% to 90% necrosis in both types of tumors. However, tumor necrosis induced by the cellular targeting PDT (1 mg/kg verteporfin, 50 J/cm(2) at 50 mW/cm(2), 3 hours drug-light interval) was significantly different in the orthotopic (64%) versus the s.c. (29%) tumors. CONCLUSIONS Tumor host environment can significantly affect photosensitizer verteporfin distribution and PDT treatment effect. Verteporfin-PDT regimen targeting tumor cells is more sensitive to such influence than the vascular targeting PDT. Our study showed the importance of tumor host environment in determining tumor physiologic properties and tumor response to PDT. To obtain clinically relevant information, orthotopic tumor model should be used in the experimental studies.

[1]  L. K. Lee,et al.  In situ COMPARISON OF 665 nm and 633 nm WAVELENGTH LIGHT PENETRATION IN THE HUMAN PROSTATE GLAND , 1995, Photochemistry and photobiology.

[2]  G. Lapin,et al.  Absence of host-site influence on angiogenesis, blood flow, and permeability in transplanted RG-2 gliomas. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[3]  Avigdor Scherz,et al.  Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts , 2003, International journal of cancer.

[4]  R. Jain,et al.  Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Lei Xu,et al.  Pancreas Microenvironment Promotes VEGF Expression and Tumor Growth: Novel Window Models for Pancreatic Tumor Angiogenesis and Microcirculation , 2001, Laboratory Investigation.

[6]  M. Dewhirst,et al.  Concepts of oxygen transport at the microcirculatory level. , 1998, Seminars in radiation oncology.

[7]  C. Whitehurst,et al.  In vivo laser light distribution in human prostatic carcinoma. , 1994, The Journal of urology.

[8]  Rolf Muschter,et al.  Photodynamic therapy: A new approach to prostate cancer , 2003, Current urology reports.

[9]  Brian W. Pogue,et al.  Blood Flow Dynamics after Photodynamic Therapy with Verteporfin in the RIF-1 Tumor , 2003, Radiation research.

[10]  E. Janovitz,et al.  Spontaneous metastasis of PC‐3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments , 1995, The Prostate.

[11]  C. Dinney,et al.  Metastatic model for human prostate cancer using orthotopic implantation in nude mice. , 1992, Journal of the National Cancer Institute.

[12]  T. Foster,et al.  Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. , 1992, Radiation research.

[13]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[14]  J. Double,et al.  Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  S. Loening,et al.  Laser-induced hyperthermia in rat prostate cancer: role of site of tumor implantation. , 2000, Urology.

[16]  R. Jain Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.

[17]  R. Moore,et al.  Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  J. M. Henry,et al.  Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy. , 1989, The Journal of urology.

[19]  Tayyaba Hasan,et al.  Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. , 2003, Cancer research.

[20]  N. Ferrara,et al.  Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis , 1999 .

[21]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[22]  C. Bucana,et al.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.

[23]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[24]  Z. Hall Cancer , 1906, The Hospital.

[25]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia: Animal models 2000 , 2000, The Prostate.

[26]  R. Jain,et al.  Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.

[27]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Hudson,et al.  Tumor-specific and Photodependent Cytotoxicity of Hypericin in the Human LNCaP Prostate Tumor Model , 2001, Photochemistry and photobiology.

[29]  M R Arnfield,et al.  OPTICAL PROPERTIES OF EXPERIMENTAL PROSTATE TUMORS in vivo , 1993, Photochemistry and photobiology.

[30]  A. Scherz,et al.  Bypass of tumor drug resistance by antivascular therapy. , 2003, Neoplasia.

[31]  P. Olive,et al.  Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. , 1989, British Journal of Cancer.

[32]  J. Tulip,et al.  In vivo light transmission spectra in EMT6/Ed murine tumors and dunning R3327 rat prostate tumors during photodynamic therapy , 1997, Lasers in surgery and medicine.

[33]  An interstitial light assembly for photodynamic therapy in prostatic carcinoma , 1999, BJU international.

[34]  E. Gilboa,et al.  An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer , 1994, The Prostate.

[35]  F W Hetzel,et al.  Laser dosimetry studies in the prostate. , 1998, Journal of clinical laser medicine & surgery.

[36]  John Tulip,et al.  Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid. , 2002, Urologic oncology.

[37]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[38]  B. Pogue,et al.  Assessment of Photosensitizer Dosimetry and Tissue Damage Assay for Photodynamic Therapy in Advanced-stage Tumors¶ , 2004 .

[39]  Michael R Hamblin,et al.  Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. , 1998, Cancer research.

[40]  B. Pogue,et al.  Analysis of Effective Molecular Diffusion Rates for Verteporfin in Subcutaneous Versus Orthotopic Dunning Prostate Tumors¶ , 2004, Photochemistry and photobiology.